Division of Nephrology, Department of Internal Medicine, University of Arkansas for Medical Sciences, Little Rock, Arkansas; Renal Medicine Section, Medical Service, Central Arkansas Veterans Healthcare System, Little Rock, Arkansas.
Division of Nephrology, Department of Internal Medicine, University of Arkansas for Medical Sciences, Little Rock, Arkansas; Renal Medicine Section, Medical Service, Central Arkansas Veterans Healthcare System, Little Rock, Arkansas.
J Ren Nutr. 2017 Nov;27(6):462-464. doi: 10.1053/j.jrn.2017.05.004.
Acute kidney injury (AKI) occurs in approximately 10% to 15% of hospital-admitted patients and is associated with in-hospital mortality of 50% in patients requiring renal replacement therapy. Recently, multiple observational studies have demonstrated that patients who survive AKI have significant long-term consequences including cardiovascular events, progression to advanced-stage chronic kidney disease (CKD), and mortality. A direct link between AKI and CKD is provided by studies that demonstrate that some patients with normal renal function who develop AKI requiring dialysis never recover. In addition, in a large pediatric AKI population, 10% of the cohort developed CKD within 1 to 3 years. In a systemic review and meta-analysis in which 13 cohort studies were analyzed, patients with AKI had a hazard ratio (HR) of 8.8 for developing CKD, HR of 3.1 of developing end-stage kidney disease, and HR of 2.0 for mortality. AKI was also independently associated with risk for cardiovascular disease and congestive heart failure. These studies indicate that AKI is associated with important, long-term consequences and that AKI has become an important contributor to the end-stage kidney disease population. Prospective ongoing studies will better define the cause-effect relationship and delineate potential biomarkers that would identify AKI patients at risk for CKD, cardiovascular events, and mortality.
急性肾损伤(AKI)发生在大约 10%至 15%的住院患者中,在需要肾脏替代治疗的患者中,院内死亡率为 50%。最近,多项观察性研究表明,存活的 AKI 患者存在显著的长期后果,包括心血管事件、进展为晚期慢性肾脏病(CKD)和死亡。AKI 与 CKD 之间的直接联系是由一些研究提供的,这些研究表明,一些肾功能正常但发展为需要透析的 AKI 的患者从未恢复。此外,在一个大型儿科 AKI 人群中,10%的队列在 1 至 3 年内发展为 CKD。在一项系统评价和荟萃分析中,分析了 13 项队列研究,AKI 患者发生 CKD 的风险比(HR)为 8.8,发生终末期肾病的 HR 为 3.1,死亡率的 HR 为 2.0。AKI 也与心血管疾病和充血性心力衰竭的风险独立相关。这些研究表明,AKI 与重要的长期后果相关,并且 AKI 已成为终末期肾病患者的一个重要贡献因素。正在进行的前瞻性研究将更好地定义因果关系,并描绘潜在的生物标志物,以识别有发生 CKD、心血管事件和死亡风险的 AKI 患者。